JPS57112331A - Medical composition of ganoderma lucidum component - Google Patents

Medical composition of ganoderma lucidum component

Info

Publication number
JPS57112331A
JPS57112331A JP55187752A JP18775280A JPS57112331A JP S57112331 A JPS57112331 A JP S57112331A JP 55187752 A JP55187752 A JP 55187752A JP 18775280 A JP18775280 A JP 18775280A JP S57112331 A JPS57112331 A JP S57112331A
Authority
JP
Japan
Prior art keywords
thrombosis
ganoderma lucidum
hypertension
reagent
positive
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP55187752A
Other languages
Japanese (ja)
Other versions
JPH0148249B2 (en
Inventor
Takeshi Takahashi
Shigeru Yuchi
Michitoku Kubo
Tadahito Tani
Masaya Toyama
Masakatsu Masumori
Norimasa Kirigatani
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
TOYO YAKUSHIYOKU KOGYO KK
Original Assignee
TOYO YAKUSHIYOKU KOGYO KK
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by TOYO YAKUSHIYOKU KOGYO KK filed Critical TOYO YAKUSHIYOKU KOGYO KK
Priority to JP55187752A priority Critical patent/JPS57112331A/en
Publication of JPS57112331A publication Critical patent/JPS57112331A/en
Publication of JPH0148249B2 publication Critical patent/JPH0148249B2/ja
Granted legal-status Critical Current

Links

Landscapes

  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

PURPOSE: The titled composition useful for remedying and preventing symptomes complices of thrombosis in the blood, having low toxicity, obtained by subjecting a fruit body of ganoderma lucidum to thermal extraction with water, removing unsoluble components from the extracted solution, followed by concentration and drying.
CONSTITUTION: The titled composition comprising a medicinal component of ganoderma lucidum as an active ingredient. The medical component has the following chemical and physical properties. The maximum absorptions of infrared spectrum (KBr method) are about 3,450, 2,970, 1,700, 1,460, 1,390, and 1,040cm-1; the maximum absorption of ultraviolet spectrum is about 257W258nm; positive in Fehling's reagent, quasipositive in phenylhydrazine reagent, and positive in ninhydrine reaction. This medicinal component is known to have extremely improved effect on hypertension, hyperlipemia and arteriosclerosis, and effective for against a group of diseases, symptomes complices of thrombosis in the blood vessel, spread in a wide range, caused by the formation of thrombosis in the blood vessel, especially thrombosis with hypertension. An oral dose is 10W 300mg/time, and 2W3 times a day.
COPYRIGHT: (C)1982,JPO&Japio
JP55187752A 1980-12-29 1980-12-29 Medical composition of ganoderma lucidum component Granted JPS57112331A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP55187752A JPS57112331A (en) 1980-12-29 1980-12-29 Medical composition of ganoderma lucidum component

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP55187752A JPS57112331A (en) 1980-12-29 1980-12-29 Medical composition of ganoderma lucidum component

Publications (2)

Publication Number Publication Date
JPS57112331A true JPS57112331A (en) 1982-07-13
JPH0148249B2 JPH0148249B2 (en) 1989-10-18

Family

ID=16211574

Family Applications (1)

Application Number Title Priority Date Filing Date
JP55187752A Granted JPS57112331A (en) 1980-12-29 1980-12-29 Medical composition of ganoderma lucidum component

Country Status (1)

Country Link
JP (1) JPS57112331A (en)

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60184025A (en) * 1984-03-02 1985-09-19 Toyo Yakushiyoku Kogyo Kk Polysaccharide, separation and use thereof
JP2005162627A (en) * 2003-11-28 2005-06-23 Nippon Menaade Keshohin Kk Medicinal composition of ingredient of ganoderma atrum, ganoderma japonicum, ganoderma sinense or the like
JP2005298391A (en) * 2004-04-09 2005-10-27 Nippon Menaade Keshohin Kk Matrix metalloprotease inhibitor
JP2006028128A (en) * 2004-07-21 2006-02-02 Nippon Menaade Keshohin Kk Thrombosis ameliorating agent
JP2012131754A (en) * 2010-12-24 2012-07-12 Nippon Menaade Keshohin Kk Antithrombotic agent
CN103616339A (en) * 2013-11-07 2014-03-05 培力(南宁)药业有限公司 Detection method for preparation containing ganoderan
JP2015187176A (en) * 2015-07-21 2015-10-29 日本メナード化粧品株式会社 Antithrombotic

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60184025A (en) * 1984-03-02 1985-09-19 Toyo Yakushiyoku Kogyo Kk Polysaccharide, separation and use thereof
JP2005162627A (en) * 2003-11-28 2005-06-23 Nippon Menaade Keshohin Kk Medicinal composition of ingredient of ganoderma atrum, ganoderma japonicum, ganoderma sinense or the like
JP2005298391A (en) * 2004-04-09 2005-10-27 Nippon Menaade Keshohin Kk Matrix metalloprotease inhibitor
JP2006028128A (en) * 2004-07-21 2006-02-02 Nippon Menaade Keshohin Kk Thrombosis ameliorating agent
JP2012131754A (en) * 2010-12-24 2012-07-12 Nippon Menaade Keshohin Kk Antithrombotic agent
CN103616339A (en) * 2013-11-07 2014-03-05 培力(南宁)药业有限公司 Detection method for preparation containing ganoderan
JP2015187176A (en) * 2015-07-21 2015-10-29 日本メナード化粧品株式会社 Antithrombotic

Also Published As

Publication number Publication date
JPH0148249B2 (en) 1989-10-18

Similar Documents

Publication Publication Date Title
JPS57193412A (en) Prevention of prostatic hyperplasia and therapeutical drug
JPS57122085A (en) Circulatory disease extirpenter and use
JPS56128721A (en) Antiallergic agent
Cullen et al. Cardiovascular effects of fluroxene in man
JPS57126420A (en) Drug for digestive organ
JPS536430A (en) Preparation of anticoagulant soft material for medical use
JPS5630917A (en) Preventive and remedy for hepatitis
JPS5795914A (en) Antithrombin-like drug
JPS55122724A (en) Antidiabetic agent
KR880004810A (en) Peptic Ulcer Treatment
JPS5422777A (en) Invertible processing device
JPS5257319A (en) Anticeptic treatment of foods
JPS5428255A (en) Hastelloy-clad steellplate with superior dendability and its manufacture
JPS51126070A (en) Weber treatment equipment
JPS5639019A (en) Antiviral agent
JPS53115660A (en) Method for treating juice
JPS5435214A (en) Remedy and prophylaxis of scours of calf
IL82317A0 (en) 1,4 dihydropyridine derivatives,processes for their preparation and medicaments containing these compounds
RU92002038A (en) METHOD OF OBTAINING PROPOLIS EXTRACT
JPS57209218A (en) Antithrombotic
JPS5767521A (en) Agent for improving circulation blood vessel
JPS5241208A (en) Complete extraction of pharmaceutically active substances contained in mycelium and spores of "shiitake"
CA2030548A1 (en) Isothiocyanate vapor-generating agent, germ-destroying treatment method using isothiocyanate vapors and apparatus therefor
SU645647A1 (en) Method of lobe-wise cutout of liver from blood circulation
JPS55118420A (en) Preparation of improved vaccine for hooping cough